• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Artiva Biotherapeutics released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 0 and EPS of USD -2.5862
04:00
Artiva Biotherapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.8793 (forecast USD -0.8683)
04:00
Oct16
Artiva Biotherapeutics Receives FDA Fast Track Designation and Plans to Meet with FDA in Early 2026
20:06
Aug7
Artiva Biotherapeutics released FY2025 Q2 earnings on August 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.8718 (forecast USD -0.8066)
03:00
Artiva Biotherapeutics released FY2025 Semi-Annual earnings on August 6 (EST), actual revenue USD 0, actual EPS USD -1.7062
03:00
Jun11
HC Wainwright Reiterates Buy Rating on Artiva Biotherapeutics
12:26

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -21.53 M, EPS -0.8793

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -21.25 M, EPS -0.8718

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -20.31 M, EPS -0.8344

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
GURE
8.190
+72.78%
+3.450
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
View More